Latest News
Bobby Previti, a former welder who rose to become a Managing Director at Bank of America, is set to join a hedge fund following his departure from the US bank’s London trading desk, according to a report by eFinancial Careers citing market sources.
Newly established Charlotte, North Carolina-headquartered hedge fund Black Pill Capital has launched with a new strategy centred on investing in companies looking to adopt bitcoin as a corporate treasury asset.
Elliott Management has disclosed a $4bn stake in PepsiCo, marking one of the activist hedge fund’s largest positions to date, as it pushes for a shake-up at the global drinks and snacks group to reverse a sharp share price decline, according to a report by the Financial Times.
Leading multi-strategy hedge funds, including Citadel and ExodusPoint delivered positive performance in August, buoyed by steady gains in global equity markets, though results varied across firms, according to a report by Business Insider.
Nagaraj Pangal, Nomura’s former Co-Global Head of FX and Emerging Markets, has resurfaced at multi-strategy hedge fund Verition, where he will run an emerging markets macro strategy as a Portfolio Manager in Singapore, according to a report by eFinancial Careers.
Magnetar, the credit-focused hedge fund that rose to prominence during the 2008 financial crisis, has posted one of the industry’s strongest returns this year after a bold wager on AI infrastructure firm CoreWeave delivered outsized gains, according to a report by the Financial Times.
Digital assets funds saw inflows of $2.48bn last week, lifting August inflows to $4.37bn and YTD flows to $35.5bn, though AUM slipped 10% to $219bn, according to a the latest Digital Assets Fund Flows Weekly Report from CoinShares.
Hedge funds have been increasing their exposure to WPP, the world’s largest advertising and marketing group, just as Cindy Rose begins her tenure as Chief Executive Officer, according to a report by Reuters citing research from Panmure Liberum.
Hedge funds saw a boost in July thanks to a rally in French biotech Abivax, as its US-listed shares jumped more than 580% in a single day following positive Phase 3 trial results for its ulcerative colitis oral treatment obefazimod, according to a report by the Wall Street Journal.
Singapore-headquartered hedge fund Dymon Asia has extended its 2025 rebound, with its $3.5bn multi-strategy fund rising 1.75% in August, lifting year-to-date returns to 12%, according to a report by Financial News citing people familiar with the matter.
Special Reports
FeatureD
- Insight
